Pin-fang Lin
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Hepatitis C virus research, Click Chemistry and Applications, HIV-related health complications and treatments
Most-Cited Works
- → Discovery of 4-Benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): A Novel HIV-1 Attachment Inhibitor That Interferes with CD4-gp120 Interactions(2003)206 cited
- → HIV-1 entry – an expanding portal for drug discovery(2000)73 cited
- → Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns(2009)62 cited
- → A survey of core replacements in indole-based HIV-1 attachment inhibitors(2019)24 cited
- → Corrigendum to “Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns” [Bioorg. Med. Chem. Lett. 19 (2009) 1977](2010)2 cited
- → Corrigendum to “Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives” [Bioorg. Med. Chem. Lett. 19 (2009) 5140](2010)2 cited
- → Corrigendum to “Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activity” [Bioorg. Med. Chem. Lett. 19 (2009) 5136](2010)1 cited